Euclises Pharmaceuticals, Inc.
Industry: Pharmaceuticals (See others in industry)
Address:
4320 Forest Park Avenue, Suite 303
St. Louis, MO, 63108
Phone: (314) 604-2850
St. Louis, MO, 63108
Phone: (314) 604-2850
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2016-12-01 | Amended | $1,216,913 | $1,216,913 | Equity Only | 06c | SEC link |
| 2015-10-01 | Amended | $1,851,250 | $1,551,250 | Equity Only | 06b | SEC link |
| 2015-10-01 | New | Yet to Sell | $0 | Equity Only | 06c | SEC link |
| 2014-01-13 | New | $300,000 | $300,000 | Equity Only | 06b | SEC link |
| 2012-05-17 | New | $174,998 | $174,998 | Equity Only | 06 | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Robert A. Beardsley | Director |
| Charles A. Bolten | Director |
| Robert J. Calcaterra | Director |
| Rajesh Devraj | Director |
| Robert W. Karr | Director, Executive |
| Eduardo J. Martinez | Director |
| Rick Ryan | Director |
| Bobby W. Sandage, Jr. | Director, Executive |
| John J. Talley | Director |
| Randy H. Weiss | Director, Executive |